Agomelatine and sertraline for the treatment of depression in type 2 diabetes mellitus

Type 2 Diabetes

(2013) Sandeep Vijan   ANNALS OF INTERNAL MEDICINE

Does treatment of subsyndromal depression improve depression and diabetes related outcomes: protocol for a randomised controlled comparison of psycho-education, physical exercise and treatment as usual

(2013) Mirjana Pibernik-Okanović et al.   Trials

Antidepressant efficacy of agomelatine versus SSRI/SNRI

(2012) Siegfried Kasper et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Relationships among depression, anxiety, self-care behaviour and diabetes education difficulties in patients with type-2 diabetes: A cross-sectional questionnaire survey

(2011) Shu-Fang Vivienne Wu et al.   INTERNATIONAL JOURNAL OF NURSING STUDIES

Mode of action of agomelatine: Synergy between melatonergic and 5-HT2Creceptors

(2011) Giorgio Racagni et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

Treatment of depression in diabetes: an update

(2009) Frank Petrak et al.   CURRENT OPINION IN PSYCHIATRY

Pathways linking socioeconomic status to obesity through depression and lifestyle factors among young US adults

(2009) May A. Beydoun et al.   JOURNAL OF AFFECTIVE DISORDERS

The Comorbidity of Diabetes Mellitus and Depression

(2008) Wayne J. Katon   AMERICAN JOURNAL OF MEDICINE

Symptoms of depression prospectively predict poorer self-care in patients with Type 2 diabetes

(2008) J. S. Gonzalez et al.   DIABETIC MEDICINE

Examining a Bidirectional Association Between Depressive Symptoms and Diabetes

(2008) Sherita Hill Golden   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION